Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ironwood Pharmaceuticals (IRWD) Asset Utilization Ratio: 2011-2024

Historic Asset Utilization Ratio for Ironwood Pharmaceuticals (IRWD) over the last 14 years, with Dec 2024 value amounting to 0.86.

  • Ironwood Pharmaceuticals' Asset Utilization Ratio fell 4.83% to 0.92 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.92, marking a year-over-year decrease of 4.83%. This contributed to the annual value of 0.86 for FY2024, which is 51.76% up from last year.
  • Per Ironwood Pharmaceuticals' latest filing, its Asset Utilization Ratio stood at 0.86 for FY2024, which was up 51.76% from 0.56 recorded in FY2023.
  • In the past 5 years, Ironwood Pharmaceuticals' Asset Utilization Ratio ranged from a high of 0.86 in FY2024 and a low of 0.37 during FY2022.
  • Over the past 3 years, Ironwood Pharmaceuticals' median Asset Utilization Ratio value was 0.56 (recorded in 2023), while the average stood at 0.60.
  • As far as peak fluctuations go, Ironwood Pharmaceuticals' Asset Utilization Ratio tumbled by 39.40% in 2021, and later spiked by 52.83% in 2023.
  • Over the past 5 years, Ironwood Pharmaceuticals' Asset Utilization Ratio (Yearly) stood at 0.81 in 2020, then tumbled by 39.40% to 0.49 in 2021, then declined by 24.88% to 0.37 in 2022, then soared by 52.83% to 0.56 in 2023, then spiked by 51.76% to 0.86 in 2024.